Journal of Cachexia Sarcopenia and Muscle

The Journal of Cachexia, Sarcopenia and Muscle is a quarterly fully open-access journal published by Wiley in association with the Society on Sarcopenia, Cachexia and Wasting Disorders, established in 2010 and devoted to cachexia, sarcopenia and changes in body composition across the lifespan and in illness, with a 2025 Journal Impact Factor of 9.9《恶病质·肌少症与肌肉》（JCSM）是由 Wiley 出版并与（Society on Sarcopenia Cachexia and Wasting Disorders）关联的开放获取季刊，2010 年创办，聚焦恶病质、肌少症以及贯穿生命周期与疾病过程的身体成分变化，2025 年影响因子为 9.9。

Scope

• The journal publishes peer-reviewed material related to cachexia and sarcopenia, as well as body composition and its physiological and pathophysiological changes during the lifespan and in response to different illnesses from all fields of the life sciences该刊发表与恶病质和肌少症相关的同行评审材料，并覆盖身体成分及其在生命周期中、以及在生命科学各领域不同疾病应答下的生理与病理生理变化。
• Cachexia denotes involuntary weight loss occurring during many chronic diseases and is among the most debilitating and life-threatening features of advanced illness, while sarcopenia describes the age-related loss of muscle mass and function恶病质指许多慢性病过程中出现的非自主性体重下降，是进展期疾病最具消耗性与生命威胁的特征之一；肌少症则描述与年龄相关的肌肉量与功能流失。
• It serves an international readership of physicians, biochemists, biologists, dietitians, pharmacologists and students who work on muscle wasting and metabolic disorders该刊服务于研究肌肉消耗与代谢障碍的临床医生、生物化学家、生物学家、营养师、药理学家与学生等国际读者群。
• Content spans original research, systematic reviews and meta-analyses, together with editorials and perspectives that link basic mechanisms with clinical practice内容涵盖原创研究、系统综述与荟萃分析，以及连接基础机制与临床实践的社论和观点文章。
• The journal is fully open access, so every accepted article is freely available to read, download and share immediately on publication该刊为完全开放获取期刊，每篇录用文章在发表后即可免费阅读、下载与传播。
• It is abstracted and indexed in the Science Citation Index Expanded, Embase and Scopus, and holds the first quartile in both the geriatrics and gerontology category and the general and internal medicine category该刊被（SCIE）、（Embase）与（Scopus）收录，在老年医学与综合内科两个类别均位居第一四分位。

History

• The journal was established in 2010 and was originally published by Springer Science+Business Media from Berlin该刊 2010 年创办，最初由柏林的施普林格（Springer）出版。
• Since January 2015 the journal has been published by Wiley-Blackwell in association with the Society on Sarcopenia, Cachexia and Wasting Disorders自 2015 年 1 月起，该刊改由威立（Wiley-Blackwell）出版，并与（Society on Sarcopenia Cachexia and Wasting Disorders）建立关联。
• The inaugural volume dated 2010 carried joint consensus definitions of cachexia, pre-cachexia and sarcopenia that helped standardise the field该刊 2010 年的创刊卷刊载了恶病质、恶病质前期与肌少症的联合共识定义，为该领域确立规范。
• Two daughter journals, JCSM Clinical Reports and JCSM Rapid Communications, were launched in 2016 to cover clinical and basic-science output respectively2016 年该刊创办两本子刊 JCSM Clinical Reports 与 JCSM Rapid Communications，分别面向临床与基础研究。
• Its impact factor has remained high, recorded at 12.91 for 2021 and 12.063 for 2022 before settling at 9.1 for 2024 and 9.9 for 2025其影响因子长期居高，2021 年为 12.91，2022 年为 12.063，此后 2024 年为 9.1，2025 年为 9.9。
• The journal is issued quarterly and published in English, with its editorial office hosted by the publisher in Hoboken in the United States该刊按季出版并以英文发行，编辑部设于美国霍博肯（Hoboken）的出版方办公地。

Editors

• The founding editors-in-chief are Stefan D. Anker of the Charite medical university in Berlin and Stephan von Haehling of the University of Gottingen创刊主编为柏林夏里特医学院（Charite）的（Stefan D. Anker）与哥廷根大学（University of Gottingen）的（Stephan von Haehling）。
• Both editors-in-chief come from cardiology and metabolism divisions, reflecting the journal's origins in heart-failure and wasting research两位主编均来自心脏病学与代谢病学科，体现该刊源于心力衰竭与消耗综合征研究的背景。
• Stephan von Haehling has taken a leading role in day-to-day editorship and authors the periodic ethical-guidelines and progress editorials of the journal（Stephan von Haehling）承担日常主编工作，并定期撰写该刊的伦理准则与年度进展社论。
• An international editorial board of specialists in geriatrics, oncology, nutrition, pulmonology and intensive care supports the editors in handling submissions一支由老年医学、肿瘤学、营养学、呼吸医学与重症医学专家组成的国际编委会协助主编处理稿件。
• Stefan D. Anker and the editorial team have shaped JCSM into a cross-disciplinary venue that connects mechanistic cachexia and sarcopenia research with clinical intervention（Stefan D. Anker）及其编团队伍将 JCSM 打造成连接恶病质与肌少症机制研究和临床干预的跨学科平台。